Immunosuppressants in dermatology on vaccine immunogenicity: a prospective cohort study of pemphigus patients in the pandemic.

15.4 [1.5]; p = 0.020) ( Figure 3D ), and near-significant elevations in percentages of both CD8 + T cells and naïve CD4 + T cells. 4 Discussion The COVID-19 pandemic is reminiscent of the dilemma in our daily practice, which is to maintain adequate immunosuppression for controlling autoimmune diseases while risking a higher probability of non-responsiveness to vaccination ( 12 , 13 ).

also in 1,917 other papers

These trends were also noticed in patients receiving their third vaccination, though some did not reach statistical significance.

also in 83,712 other papers